{Reference Type}: Journal Article
{Title}: The mechanisms in the gut microbiota regulation and type 2 diabetes therapeutic activity of resistant starches.
{Author}: Li X;Chen R;Wen J;Ji R;Chen X;Cao Y;Yu Y;Zhao C;
{Journal}: Int J Biol Macromol
{Volume}: 274
{Issue}: 0
{Year}: 2024 Jun 19
{Factor}: 8.025
{DOI}: 10.1016/j.ijbiomac.2024.133279
{Abstract}: Resistant starch (RS) can potentially prevent type 2 diabetes through the modulation of intestinal microbiota and microbial metabolites. Currently, it has been wildly noted that altering the intestinal microbial composition and short-chain fatty acids levels can achieve therapeutic effects, although the specific mechanisms were rarely elucidated. This review systematically explores the structural characteristics of different RS, analyzes the cross-feeding mechanism utilized by intestinal microbiota, and outlines the pathways and targets of butyrate, a primary microbial metabolite, for treating diabetes. Different RS types may have a unique impact on microbiota composition and their cross-feeding, thus exploring regulatory mechanisms of RS on diabetes through intestinal flora interaction and their metabolites could pave the way for more effective treatment outcomes for host health. Furthermore, by understanding the mechanisms of strain-level cross-feeding and metabolites of RS, precise dietary supplementation methods targeted at intestinal composition and metabolites can be achieved to improve T2DM.